Positive benefit of postnatal treatment in congenital toxoplasmosis
Arch Dis Child
.
2007 Jan;92(1):88-9.
Authors
J E Gomez-Marin
,
A delaTorre
PMID:
17185453
PMCID:
PMC2083129
No abstract available
Publication types
Comment
Letter
MeSH terms
Antiprotozoal Agents / therapeutic use*
Colombia / epidemiology
Humans
Infant, Newborn
Mass Screening
Toxoplasmosis, Congenital / drug therapy*
Toxoplasmosis, Congenital / mortality
Substances
Antiprotozoal Agents